Vasodilator drugs and peripheral vascular disease.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D005632:Fructose / Q000627:therapeutic use; D006801:Humans; D007294:Inositol / Q000627:therapeutic use; D007383:Intermittent Claudication / Q000188:drug therapy; D007556:Isoxsuprine / Q000627:therapeutic use; D008333:Mandelic Acids / Q000627:therapeutic use; D013948:Moxisylyte / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D003510:Cyclohexanes; D008333:Mandelic Acids; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D005632:Fructose; D007294:Inositol; D013948:Moxisylyte; D007556:Isoxsuprine